|
|
Stem Cell Source
Osiris' stem cells are derived from human bone marrow. The source marrow is voluntarily donated by healthy adults between the ages of 18 and 30 years. Blood samples from the donor are screened prior to donation for transmissible diseases, including HIV and hepatitis, and the medical and social history of each donor is obtained to ascertain whether signs, symptoms or behaviors consistent with high risk for carrying a disease are present. The health of the donor is then monitored for up to five years after donation to further ensure his/her health status. A board certified physician performs the marrow extraction procedure, and these marrow samples are immediately sent to Osiris via overnight delivery. Further testing at Osiris ensures that the stem cell population in the donated marrow is viable and of the appropriate type for use in the company’s products.
Because of the nature of Osiris’ stem cell source and the great care taken to ensure safety and quality of the material, the ethical, health and practical concerns that hamper the development of other stem cell products are avoided. This is primarily the reason Osiris has progressed into the human clinical trial phase faster than any other stem cell company.
|
 |
 |
 |
Adult immune privileged mesenchymal stem cells for use in clinical patients unrelated to the donor:
Osiris was founded in 1992 to develop Dr. Arnold Caplan and his colleagues' innovative technology for isolating and expanding mesenchymal stem cells (MSC) derived from donated bone marrow for therapeutic drug products.
|
|